MC1068A1 - Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent - Google Patents

Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent

Info

Publication number
MC1068A1
MC1068A1 MC751158A MC1158A MC1068A1 MC 1068 A1 MC1068 A1 MC 1068A1 MC 751158 A MC751158 A MC 751158A MC 1158 A MC1158 A MC 1158A MC 1068 A1 MC1068 A1 MC 1068A1
Authority
MC
Monaco
Prior art keywords
group
radical
amino
hydrogen atom
hydroxy
Prior art date
Application number
MC751158A
Other languages
English (en)
French (fr)
Inventor
Howard John Schaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10402412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC1068(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1068A1 publication Critical patent/MC1068A1/fr
Priority to MC1158D priority Critical patent/MC185A7/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MC751158A 1974-09-02 1975-09-02 Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent MC1068A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MC1158D MC185A7 (fr) 1975-09-02 1977-03-01 Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38278/74A GB1523865A (en) 1974-09-02 1974-09-02 Purine compunds and salts thereof

Publications (1)

Publication Number Publication Date
MC1068A1 true MC1068A1 (fr) 1976-05-21

Family

ID=10402412

Family Applications (1)

Application Number Title Priority Date Filing Date
MC751158A MC1068A1 (fr) 1974-09-02 1975-09-02 Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent

Country Status (35)

Country Link
US (3) US4294831A (de)
JP (1) JPS5154589A (de)
AR (4) AR220299A1 (de)
AT (1) AT354462B (de)
AU (1) AU503160B2 (de)
BE (1) BE833006A (de)
BG (4) BG26536A4 (de)
CA (1) CA1062257A (de)
CH (7) CH626363A5 (de)
CS (2) CS203093B2 (de)
CY (1) CY1033A (de)
DD (1) DD122092A5 (de)
DE (1) DE2539963C2 (de)
DK (1) DK146595C (de)
ES (3) ES440631A1 (de)
FI (1) FI60709C (de)
FR (1) FR2282892A1 (de)
GB (1) GB1523865A (de)
HK (1) HK84379A (de)
HU (1) HU176730B (de)
IE (1) IE42282B1 (de)
IL (1) IL48035A (de)
KE (1) KE3002A (de)
LU (1) LU73304A1 (de)
MC (1) MC1068A1 (de)
MY (1) MY8200191A (de)
NL (1) NL175061C (de)
NO (1) NO144216C (de)
NZ (1) NZ178556A (de)
RO (4) RO74276A (de)
SE (1) SE428562C (de)
SU (7) SU904523A3 (de)
YU (4) YU39947B (de)
ZA (1) ZA755574B (de)
ZM (1) ZM12875A1 (de)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
AU521577B2 (en) * 1977-02-24 1982-04-22 Wellcome Foundation Limited, The 9-hydroxyethoxymethyl guanine phosphates
US4287188A (en) 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
JPS57102818A (en) * 1980-10-15 1982-06-26 Wellcome Found Treatment for fish virus diseases
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4603219A (en) * 1981-05-21 1986-07-29 Syntex (U.S.A.) Inc. 1,3-dibenzyloxy-2-acetoxymethoxypropane, intermediate for 9-(1,3-dihydroxy-2-propoxymethyl)guanine
FI76086C (fi) * 1981-08-11 1988-09-09 Wellcome Found Foerfarande foer framstaellning av antivirala purinderivat.
ES515733A0 (es) * 1981-09-16 1984-04-01 Ens Bio Logicals Inc "procedimiento para preparar derivados de 9-(etoximetil)-guanina".
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
ATE24836T1 (de) * 1982-02-12 1987-01-15 Ens Bio Logicals Inc Antivirale zusammensetzungen.
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
US4649140A (en) * 1982-10-14 1987-03-10 Burroughs Wellcome Co. Purine derivatives
US5059604A (en) * 1982-10-14 1991-10-22 Burroughs Wellcome Co. 2-amino purine derivatives
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
KR890001487B1 (ko) * 1982-10-14 1989-05-04 더 웰컴 파운데이숀 리미티드 푸린 유도체의 제조방법
US4745119A (en) * 1982-10-14 1988-05-17 Burroughs Wellcome Co. Method for using purine derivatives
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
ES8403904A1 (es) * 1983-02-25 1984-04-01 Ind Farma Especial Un procedimiento para la preparacion de acicloguanosina.
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
ZA844744B (en) * 1983-06-24 1986-02-26 Merck & Co Inc Antiviral agents
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
US4918219A (en) * 1983-10-31 1990-04-17 Warner-Lambert Company Glycerine derivatives
ZA848080B (en) * 1983-10-31 1985-06-26 Warner Lambert Co Purine derivatives
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
DK163985A (da) * 1984-04-13 1985-10-14 Wellcome Found Antivirale purinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3585643D1 (de) 1984-07-03 1992-04-23 Wellcome Found Antiviren-verbindungen, behandlung und formulierungen.
EP0190123A1 (de) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulierende und antivirale verbindung
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5683990A (en) * 1985-03-16 1997-11-04 Glaxo Wellcome Inc. Treatment of human viral infections
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
DE3667058D1 (en) 1985-05-02 1989-12-28 Wellcome Found Antiviral compounds
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
EP0290496B2 (de) * 1986-10-06 1995-12-20 The University Of Virginia Alumni Patents Foundation Verwendung einer adenosin, hypoxanthin und ribose enthaltender lösung zur schonung des herzens während chirurgischer eingriffe
US4916225A (en) * 1986-11-25 1990-04-10 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr 9-substituted guanines
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US4835104A (en) * 1987-06-16 1989-05-30 Ajinomoto Co., Inc., Patent & Licensing Department Process for producing and purifying 2',3'-dideoxynucleosides, and process for producing 2',3'-dideoxy-2',3'-didehydronucleosides
US6306647B1 (en) 1987-06-16 2001-10-23 Ajinomoto Co., Inc. Process for producing and purifying 2′,3′-dideoxynucleosides, and process for producing 2′,3′-dideoxy-2′,3′-didehydronucleosides
GB8725939D0 (en) * 1987-11-05 1987-12-09 Wellcome Found Therapeutic compounds
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
CA1302887C (en) * 1987-11-24 1992-06-09 Yves Langelier Combination of acyclovir or a derivative thereof and bacitracin
JPH01121424U (de) * 1988-02-10 1989-08-17
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
JPH02164881A (ja) * 1988-10-24 1990-06-25 Wellcome Found Ltd:The 治療用ヌクレオシド化合物
WO1990009178A1 (en) * 1989-01-31 1990-08-23 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
GB8907173D0 (en) * 1989-03-30 1989-05-10 Beecham Group Plc Novel compounds
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
DK169121B1 (da) 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE59310344D1 (de) * 1992-09-24 2003-07-24 Hoechst Ag N1-Substituierte 1H-1,2,3-Triazolo[4,5-d]pyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
IT1264599B1 (it) * 1993-06-14 1996-10-04 Solar Chem Sa Processo per la sintesi della 9-(2-idrossietossimetil)- guanina
US5567816A (en) * 1994-07-26 1996-10-22 Syntex (U.S.A.) Inc. Preparation of acyclovir using 1,3 dioxolane
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5840891A (en) * 1994-07-28 1998-11-24 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
IN179493B (de) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
US5789589A (en) * 1996-04-22 1998-08-04 Drug Innovation & Design, Inc. Guanine analog phosphates
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
RU2111967C1 (ru) * 1996-09-26 1998-05-27 Генкин Дмитрий Дмитриевич Способ получения ацикловира
CA2289969A1 (en) 1997-05-15 1998-11-19 Drug Innovation & Design, Inc. Acyclovir diester derivatives
US6180790B1 (en) 1997-05-15 2001-01-30 Drug Innovation And Design, Inc. Methods of preparing acyclovir prodrugs
RU2160105C1 (ru) * 2000-04-27 2000-12-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противовирусное средство и способ его получения
RU2179851C1 (ru) * 2000-12-21 2002-02-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противовирусный фармацевтический состав
RU2175230C1 (ru) * 2001-01-23 2001-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция с противовирусной активностью и способ ее получения
BR0213323A (pt) * 2001-10-16 2005-01-25 Avanir Pharmaceuticals Inibição viral por n-docosanol
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
EP1440072A4 (de) * 2001-10-30 2005-02-02 Conforma Therapeutic Corp Purinanaloga mit hsp90-inhibierender wirkung
WO2004048380A1 (en) 2002-11-22 2004-06-10 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
RU2233842C1 (ru) * 2003-01-13 2004-08-10 Петров Владимир Иванович Производные пурина, обладающие противовирусной активностью
EA015145B1 (ru) 2003-01-14 2011-06-30 Джилид Сайэнс, Инк. Фармацевтическая композиция и пероральная фармацевтическая дозированная форма (варианты), проявляющие активность в отношении вич-инфекций, лечебный набор и таблетка и способ лечения или предотвращения симптомов или эффектов вич-инфекции
US20040200730A1 (en) * 2003-04-14 2004-10-14 Kyo Jibiki Hydrometallurgical copper recovery process
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
EP2001488A4 (de) * 2006-03-14 2009-11-25 Alt Solutions Inc Prävention und behandlung von krebs und anderen erkrankungen
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
JP6104504B2 (ja) 2008-12-23 2017-03-29 ギリアド ファーマセット エルエルシー ヌクレオシド類似体
TW201026715A (en) 2008-12-23 2010-07-16 Pharmasset Inc Nucleoside phosphoramidates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
CL2011000716A1 (es) 2010-03-31 2012-04-20 Gilead Pharmasset Llc Formas cristalinas 1 6 de (s)-isopropil-2-(((s)-(((2r.3r.4r.5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metil tetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato; composicion y combinacion farmaceutica; y su uso para tratar una infeccion por el virus de la hepatitis c.
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines

Also Published As

Publication number Publication date
CH628897A5 (de) 1982-03-31
AR220508A1 (es) 1980-11-14
IL48035A0 (en) 1975-11-25
FI60709C (fi) 1982-03-10
NL7510342A (nl) 1976-03-04
HK84379A (en) 1979-12-14
ES455978A1 (es) 1978-01-16
CH629805A5 (de) 1982-05-14
DK146595C (da) 1984-04-24
CH626364A5 (de) 1981-11-13
NO753009L (de) 1976-03-03
AT354462B (de) 1979-01-10
CH629206A5 (de) 1982-04-15
IE42282L (en) 1976-03-02
CY1033A (en) 1980-08-01
ATA676375A (de) 1979-06-15
RO74275A (ro) 1981-09-24
YU120082A (en) 1982-08-31
ES455979A1 (es) 1978-01-16
DE2539963C2 (de) 1987-01-22
AU503160B2 (en) 1979-08-23
HU176730B (en) 1981-04-28
MY8200191A (en) 1982-12-31
FI752465A7 (de) 1976-03-03
NO144216C (no) 1981-07-15
RO74274A (ro) 1981-09-24
US4323573A (en) 1982-04-06
US4360522A (en) 1982-11-23
YU222075A (en) 1982-08-31
BG25094A3 (bg) 1978-07-12
SE7509675L (sv) 1976-03-03
AR220885A1 (es) 1980-12-15
BE833006A (fr) 1976-03-02
CS203093B2 (en) 1981-02-27
SE428562C (sv) 1985-11-18
RO74276A (ro) 1981-06-26
AU8445975A (en) 1977-03-10
NL175061B (nl) 1984-04-16
SU858569A3 (ru) 1981-08-23
CA1062257A (en) 1979-09-11
SU904523A3 (ru) 1982-02-07
YU39947B (en) 1985-06-30
RO76939A (ro) 1981-06-22
CH623587A5 (de) 1981-06-15
DD122092A5 (de) 1976-09-12
IE42282B1 (en) 1980-07-16
DK146595B (da) 1983-11-14
FR2282892A1 (fr) 1976-03-26
FR2282892B1 (de) 1980-04-25
AR220299A1 (es) 1980-10-31
CH623586A5 (de) 1981-06-15
SE428562B (sv) 1983-07-11
DK392675A (da) 1976-03-03
BG26536A4 (bg) 1979-04-12
SU751325A3 (ru) 1980-07-23
SU686618A3 (ru) 1979-09-15
FI60709B (fi) 1981-11-30
SU700064A3 (ru) 1979-11-25
YU120182A (en) 1982-08-31
YU119982A (en) 1982-08-31
YU40079B (en) 1985-06-30
US4294831A (en) 1981-10-13
SU799664A3 (ru) 1981-01-23
CS203092B2 (en) 1981-02-27
DE2539963A1 (de) 1976-03-18
IL48035A (en) 1981-07-31
ZA755574B (en) 1977-04-27
BG26389A3 (bg) 1979-03-15
ES440631A1 (es) 1977-06-16
GB1523865A (en) 1978-09-06
CH626363A5 (de) 1981-11-13
KE3002A (en) 1979-12-14
SU784777A3 (ru) 1980-11-30
LU73304A1 (de) 1976-08-13
JPS6147839B2 (de) 1986-10-21
NL175061C (nl) 1984-09-17
NZ178556A (en) 1978-09-25
BG24815A3 (bg) 1978-05-12
ZM12875A1 (en) 1977-09-21
YU40080B (en) 1985-06-30
AR212914A1 (es) 1978-11-15
NO144216B (no) 1981-04-06
JPS5154589A (en) 1976-05-13

Similar Documents

Publication Publication Date Title
US12428442B2 (en) Compounds, compositions and methods for synthesis
TW420663B (en) Indole compounds for cyclic nucleotide-PDEs inhibitors
EP2406263B1 (de) Pyrazolo[1,5-a]-1,3,5-triazinderivate, herstellung davon und therapeutische verwendung davon
US8383636B2 (en) Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
JPS6147839B2 (de)
MC1968A1 (fr) Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant
MC1743A1 (fr) Nouveaux dérivés de la xanthine leur préparation et médicaments qui en contiennent
CA2412368A1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
IL224045A (en) Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
MC1935A1 (fr) Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant
US20170275322A1 (en) Methods for the preparation of diastereomerically pure phosphoramidate prodrugs
MC1846A1 (fr) Derives de pyrimidine
JPH09124648A (ja) プリン−６−オン誘導体
FR2626002A1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
EP2024335B1 (de) Neue imidazolderivate, ihre herstellung und ihre verwendung als medizin
MC869A1 (fr) Furanosyl-aminopurines et médicament contenant ces substances
WO2002060880A1 (fr) Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation
FR2723093A1 (fr) Esters d'acyle d'acides amines achiraux du glanciclovir
MC1969A1 (fr) Procedes pour preparer des composes antitumoraux,formulation pharmaceutique contenant ces composes,leurs utilisations en medecine et pharmacie,et composes intermediaires pour leur preparation
WO2004011464A2 (fr) Nouvelles pyrazolo[1,5-a]-1,3,5-triazines substituees et leurs analogiques, compositions pharmaceutiques les contenant, utilisation a titre de medicament et procedes pour leur preparation
JPH07502740A (ja) 治療用ヌクレオシド
MC1845A1 (fr) Derives de pyrimidine
JPS6222994B2 (de)
JP2000516578A (ja) アデノシンデアミナーゼ阻害剤
MC1616A1 (fr) Derives d'imidazobenzodiazepine

Legal Events

Date Code Title Description
YP Annual fee paid